Cite
HARVARD Citation
Doi, T. et al. (2018). Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors. Cancer science. 109 (1), pp. 193-198. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Doi, T. et al. (2018). Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors. Cancer science. 109 (1), pp. 193-198. [Online].